Search

Your search keyword '"Sher, Lawrence"' showing total 296 results
Start Over Author "Sher, Lawrence"
296 results on '"Sher, Lawrence"'

3. Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study

Author

Abalos, Karina, Adams, Michael, Allaw, Mohamed, Aloysia, Naveena, Amuasi, John Humphrey, Ansah, Nana Akosua, Asante, Kwaku Poku, Benkeser, David, Berge, Aude, Breuer, Thomas, Briesemeister, Liz, Broder, Gail, Bonfanti, Alberto Cadena, Calinescu, Cornell, Canter, Richard, Carrillo, Jaime Augusto, Chansinghakul, Danaya, Coux, Florence, Das, Chandan, Davies, Matthew, Devlin, Louis, Fay, Michael, Follmann, Dean, Frago, Carina, Fukase, Hiroyuki, Garinga, Agnes, Gilbert, Peter B., Gonzalez, Claudia, Granados, Maria Angelica, Greiwe, Cathy, Guillery, Lea, Hall, Jessicalee, Henderson, Jeffrey, Huang, Ying, Hudzina, Kathy, Hural, John, Hutchens, Mark, Jain, Manish, Jennings, William, Kanodia, Piush, Kimmel, Murray, Kirby, William, Khandelwal, Nitin, Kopp, James, Kosolsak, Chalit, Kublin, Jim, Kukian, Darshna, Kushwaha, Jitendra Singh, Laot, Thelma, Lopez-Medina, Eduardo, Arroyo, Hugo Macareno, Mamod, Stephanie, Mangarule, Somnath, Martin, Troy, Menard, Lisa, Mendoza, Sandra, Meyer, Robert, Middleton, Randle, Miracle, Jill, Mizuyama, Kazuyuki, Mohapatra, Satyajit, Moreau, Catherine, Murray, Linda, Nagamatsu, Shinya, Newberg, Joseph, Noriega, Fernando, Nugent, Paul, Peake-Andrasik, Michele, Pekala, David, Peng, Penny, Py, Marie-Laure, Ramirez, Shelly, Reddy, Chinthaparthi Prabhakar, Reynolds, Michelle, Rivas, Enrique, Sater, Nessryne, Shah, Jinen, Sher, Lawrence, Sieger, Silva, Singh, Chandramani, Singh, Veer Bahadur, Sirisuphmitr, Nuchra, Starkey, Thomas, Suzuki, Kazuo, Tamrakar, Dipesh, Tangemen, Cayce, Da-Silva, Fernanda Tavares, Taylor, David, Tharenos, Leslie, Wartel, T. Anh, Zaworski, Elodie, Zhang, Nianxian, Dayan, Gustavo H., Rouphael, Nadine, Walsh, Stephen R., Chen, Aiying, Grunenberg, Nicole, Allen, Mary, Antony, Johannes, Bhate, Amit Suresh, Beresnev, Tatiana, Bonaparte, Matthew I., Celle, Médéric, Ceregido, Maria Angeles, Corey, Lawrence, Fu, Bo, Grillet, Marie-Helene, Keshtkar-Jahromi, Maryam, Juraska, Michal, Kee, Jia Jin, Kaali, Seyram, Koutsoukos, Marguerite, Masotti, Roger, Michael, Nelson L., Neuzil, Kathleen M., Reynales, Humberto, Robb, Merlin L., Uchiyama, Akiyoshi, Sawe, Fredrick, Schuerman, Lode, Shrestha, Rajeev, Tong, Tina, Treanor, John, Diazgranados, Carlos A., Chicz, Roman M., Gurunathan, Sanjay, Savarino, Stephen, and Sridhar, Saranya

Published
2023
Full Text
View/download PDF

4. The Supreme Court's Recent Rulings-A Boon For Government Contractors?

Author

Sher, Lawrence S

Subjects
United States. Supreme Court -- Cases, Letting of contracts -- Cases, Public contracts -- Cases, Company legal issue, Government contract, Business, international, Administrative Procedure Act, False Claims Act
Abstract

The Supreme Court of the United States' recent decisions in Loper Bright Enterprises et al. v. Raimondo, 603 U.S. (2024) and Corner Post v. Board of Governors, Federal Reserve System, [...]

Published
2024

5. Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3, parallel-group study

Author

de Bruyn, Guy, Wang, Joyce, Purvis, Annie, Ruiz, Martin Sanchez, Adhikarla, Haritha, Alvi, Saad, Bonaparte, Matthew I., Brune, Daniel, Bueso, Agustin, Canter, Richard M., Ceregido, Maria Angeles, Deshmukh, Sachin, Diemert, David, Finn, Adam, Forrat, Remi, Fu, Bo, Gallais, Julie, Griffin, Paul, Grillet, Marie-Helene, Haney, Owen, Henderson, Jeffrey A., Koutsoukos, Marguerite, Launay, Odile, Torres, Federico Martinon, Masotti, Roger, Michael, Nelson L., Park, Juliana, Rivera-Medina, Doris Maribel, Romanyak, Natalya, Rook, Chris, Schuerman, Lode, Sher, Lawrence D., Tavares-Da-Silva, Fernanda, Whittington, Ashley, Chicz, Roman M., Gurunathan, Sanjay, Savarino, Stephen, Sridhar, Saranya, Mohammed, Allaw, Valérie, Babin, Jennifer, Babyak, Ben-Ghezala, Ines, Breuer, Thomas, Breymeier, Corinne, Conrad, Anne, Holmqvist, Ciarrah, Costa-Araujo, Cristiana, Coux, Florence, Dellanno, Christine, Dussol, Bertrand, Essink, Brandon, Garrido, Jesús, Girodet, Pierre-Olivier, Gonzalez, Claudia, Grosbois, Marie-Ange, Hammond, Justin, He, Chelsea, Homlqvist, Ciarrah, Hudzina, Kathy, Hutchens, Mark, Jackson Booth, Peta-Gay, Joaquin, Arnel, Kandasamy, Rama, Kasztejna, Jennifer, Keefer, Michael, Kimmel, Murray, Kresge, Matthew, Laine, Fabrice, Lefebvre, Maeva, Lopez, Denise, Lourdes, Malaborbor Perpetua, Maakaroun-Vermesse, Zoha, Malishchak, Caitlin, Menard, Lisa, Mendoza, Sandra, Moore, Patrick, Mulamalla, Mounika, Mulholland, Patrick, Nicolas, Jean-Francois, Ogbuagu, Onyema, Ortiz, Juan, Perroud, Ana Paula, Peyton, Gina, Purvis, Ya-Fen, Raabe, Vanessa, Rivas, Enrique, Rouphael, Nadine, Roy, Beatrice, Sagot, Lola, Sater, Nessryne, Schwartz, Howard, Severance, Randall, Shi, Jiayuan, Sobieszczyk, Magdalena, Stevens, Charlene, Thuy, Tran Phuong, Toma, Ramy, Tong, Tina, Tourneux, Sophie, Treanor, John, Turet, Núria, Froget, Rachel, Walsh, Stephen, White, Judith, del Campo Perez, Victor, Perez Breva, Lina, Rojo Conejo, Pablo, Ruiz Antoraz, Maria Belen, Chin, Toong, Fribbens, Charlotte, Phillipson, Adrian, Kaminski, Rachel, Emmett, Stevan, Hebert, Corey, Birch, Thomas, Roberson, Russell, Zacher, Jeffrey, Gelu-Maury, Sophie, Loryne, Loron, and Davis, Yvonne

Published
2023
Full Text
View/download PDF

6. Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma

Author

Jackson, Daniel J., Bacharier, Leonard B., Phipatanakul, Wanda, Sher, Lawrence, Domingo, Christian, Papadopoulos, Nikolaos, Modena, Brian, Li, Ning, Xia, Changming, Kamal, Mohamed A., Dillon, Myles, Wolfe, Kelley, Gall, Rebecca, Amin, Nikhil, Mannent, Leda P., Laws, Elizabeth, Rowe, Paul J., Jacob-Nara, Juby A., Deniz, Yamo, Lederer, David J., Hardin, Megan, and Xu, Christine

Published
2023
Full Text
View/download PDF

7. Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

Author

Hetzel, Jorge Lima, Fiterman, Jussara, Souza Machado, Adelmir, Antila, Martti Anton, Lima, Marina Andrade, Minamoto, Suzana Erico Tanni, Blanco, Daniela Cavalet, Bezerra, Patricia Gomes de Matos, Houle, Pierre-Alain, Lemiere, Catherine, Melenka, Lyle S, Leigh, Richard, Mitchell, Patrick, Anees, Syed, Pek, Bonavuth, Chouinard, Guy, Cheema, Amarjit S, Yang, William Ho-Ching, Philteos, George, Chanez, Pascal, Bourdin, Arnaud, Devouassoux, Gilles, Taille, Camille, De Blay, Frédéric, Leroyer, Christophe, Beurnier, Antoine, Garcia, Gilles, Girodet, Pierre-Olivier, Blanc, François-Xavier, Magnan, Antoine, Wanin, Stéphanie, Just, Jocelyne, Linde, Richard, Zielen, Stefan, Förster, Karin, Geßner, Christian, Jandl, Margret, Buhl, Roland Otto, Korn, Stephanie, Kornmann, Marc Oliver, Linnhoff, Anneliese, Ludwig-Sengpiel, Andrea, Ehlers, Martin, Schmoller, Tibor, Steffen, Heiner, Hoffmann, Martin, Kirschner, Joachim, Schmidt, Olaf, Welte, Tobias, Temme, Hilke, Wand, Ori, Bar-Shai, Amir, Izbicki, Gabriel, Berkman, Neville, Fink, Gershon, Shitrit, David, Adir, Yochai, Kuna, Piotr, Rewerska, Barbara, Pisarczyk-Bogacka, Ewa, Kurbacheva, Oksana, Mikhailov, Sergey L, Vasilev, Maksim, Emelyanov, Alexander, Wali, Siraj, Albanna, Amr, van Zyl-Smit, Richard, Abdullah, Ismail, Bernhardi, David, Hoosen, Farzana, Irusen, Elvis, Kalla, Ismail, Lakha, Deepak, Mitha, Essack, Naidoo, Visvakuren, Nell, Haylene, Padayachee, Trevenesan, Reddy, Jeevren, Petrick, Friedrich, van der Walt, Eugene, Vawda, Zubar Fazal Ahmed, Park, Hae-Sim, Lee, Sang Haak, Kim, Mi-Kyeong, Park, Jung-Won, Cho, You Sook, Lee, Byung Jae, Chang, Yoon-Seok, Park, Choon-Sik, Lee, Kwan Ho, Lee, Sook Young, Yoon, HyoungKyu, Sohn, Kyoung Hee, Park, Myung Jae, Min, Kyung Hoon, Cho, Young Joo, Park, Han Ki, Lee, YongChul, Lee, Jaechun, Sheu, Chau-Chyun, Tu, Chih-Yen, Lee, Kang-Yun, Bavbek, Sevim, Gemicioglu, Bilun, Ediger, Dane, Kalkan, Ilkay Koca, Makieieva, Nataliia, Ostrovskyy, Mykola, Dytyatkovs'ka, Yevgeniya, Mostovoy, Yuriy Mykhaylovych, Lebed, Kyrylo, Yakovenko, Oleh, Adams, Atoya, Mooring, Timothy, Torres Jr, Louis, Sexton, Marvin, Thompson, Ernest, Bernstein, Jonathan A, Lisi, Paul, Chappel, Christopher M, Cole, Jeremy, Greenwald, Gary I, Jones, Conigliaro, Klein, Ryan Mitchell, Pham, David N, Spangenthal, Selwyn, Weinstein, Steven F, Windom, Hugh H, Kao, Neil L, Leong, Mila A, Mehta, Vinay, Moore, Wendy C, Bhat, Saligrama, Aish, Bassil, Meltzer, Steven M, Corren, Jonathan, Moss, Mark H, Kerwin, Edward M, Delgado, John Palsted, Lucksinger, Gregg Hudson, Thompson, Charles A, Chupp, Geoffrey, Alpizar, Sady A, Vadgama, Sanjay Virgi, Zafar, Zahid, Jacobs, Joshua S, Lugogo, NJira, Jain, Neal, Sher, Lawrence D, Andrawis, Nabil S, Fuentes, David, Boren, Eric Jason, Gonzalez, Erika G, Talreja, Neetu, Durrani, Sheharyar Sandy, Israel, Elliot, Sekhsaria, Sudhir, DeLeon, Samuel, Shukla, Mayank, Totszollosy Tarpay, Martha M, Fakih, Faisal, Hudes, Golda, Tillinghast, Jeffrey P, Korenblat, Phillip E, Shenoy, Kartik, Que, Loretta, Kureishy, Shahrukh Ahmad, Umeh, Fred Chukwuemeka, Nguyen, Vinh Nhu, Chu, Hanh Thi, Nguyen, Thuy Thi Dieu, Menzies-Gow, Andrew, Wechsler, Michael E, Brightling, Christopher E, Bednarczyk, Artur, Ponnarambil, Sandhia, Caveney, Scott, Almqvist, Gun, Gołąbek, Monika, Simonsson, Linda, Lawson, Kaitlyn, Bowen, Karin, and Colice, Gene

Published
2023
Full Text
View/download PDF

9. Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials

Author

Assa'ad, Amal H., Bernstein, David I., Bird, J. Andrew, Carr, Tara F., Carr, Warner W., Cheema, Amarjit S., Corren, Jonathan, Darter, Amy Liebl, Dorsey, Morna J., Fineman, Stanley M., Fleischer, David M., Fritz, Stephen B., Gogate, Shaila U., Greiner, Alexander N., Hampel, Frank C., Jr., Jacobs, Joshua S., Jain, Sanjeev, Jarvinen-Seppo, Kirsi, Jeong, David K., Johnston, Douglas T., Kachru, Rita, Kim, Edwin H., Koleilat, Majed, Lanser, Bruce J., Leonard, Stephanie A., Maier, Mary C., Manning, Michael E., Mansfield, Lyndon E., Matz, Jonathan, Nadeau, Kari, Ohayon, Jason A., Perez, Elena, Petroni, Daniel H., Pollard, Stephen J., Ponda, Punita, Portnoy, Jay M., Rachid, Rima, Ratner, Paul H., Robison, Rachel, Rupp, Ned T., Sanders, Georgiana M., Sharma, Hemant P., Sher, Ellen R., Sher, Lawrence D., Sher, Mandel, Shreffler, Wayne G., Siri, Dareen D., Skolnick, Helen S., Soong, Weily, Soteres, Daniel F., Spergel, Jonathan M., Stillerman, Allan, Sussman, Gordon L., Tam, Jonathan, Varshney, Pooja, Waserman, Susan, Windom, Hugh H., Wood, Robert, Yang, William H., Ciaccio, Christina, Goldsobel, Alan B., Anagnostou, Aikaterini, Beyer, Kirsten, Casale, Thomas B., Deschildre, Antoine, Fernández-Rivas, Montserrat, Hourihane, Jonathan O'B., Krawiec, Marta, Lieberman, Jay, Scurlock, Amy M., Vickery, Brian P., Smith, Alex, Tilles, Stephen A., Adelman, Daniel C., and Brown, Kari R.

Published
2022
Full Text
View/download PDF

10. Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial

Author

Pepper, Amber, Paller, Amy S, Lockshin, Benjamin, Cohen, David, Pariser, David, Siegfried, Elaine C, Simpson, Eric L, Leflein, Jeffrey, Weinberg, Jeffrey, Browning, John, Teng, Joyce, Wine Lee, Lara, Sher, Lawrence, Diaz, Lucia, Schneider, Lynda, Gonzalez, Mercedes E, Rupp, Ned, Ong, Peck, Cartwright, Robert, Sidbury, Robert, Soong, Weily, Pinter, Andreas, Wollenberg, Andreas, Schnopp, Christina, Cork, Michael J, Arkwright, Peter D, Korkosz, Anna, Bystrzanowska, Dorota, Sygula, Ewa, Zdybski, Jacek, Padlewska, Kamila, Schneider, Lynda C, Meltzer, Steven, Wang, Zhixiao, Mannent, Leda P, Amin, Nikhil, Sun, Yiping, Laws, Elizabeth, Akinlade, Bolanle, Dillon, Myles, Kosloski, Matthew P, Kamal, Mohamed A, Dubost-Brama, Ariane, Patel, Naimish, Weinreich, David M, Yancopoulos, George D, O’Malley, John T, and Bansal, Ashish

Published
2022
Full Text
View/download PDF

11. Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results

Author

Pongracic, Jacqueline A., Gagnon, Rémi, Sussman, Gordon, Siri, Dareen, Oriel, Roxanne C., Brown-Whitehorn, Terri F., Green, Todd D., Campbell, Dianne E., Anvari, Sara, Berger, William E., Bird, J. Andrew, Chan, Edmond S., Cheema, Amarjit, Chinthrajah, R. Sharon, Chong, Hey Jin, Dowling, Paul J., Fineman, Stanley M., Fleischer, David M., Gonzalez-Reyes, Erika, Kim, Edwin H., Lanser, Bruce J., MacGinnitie, Andrew, Mehta, Hemalini, Petroni, Daniel, Rupp, Ned, Schneider, Lynda C., Scurlock, Amy M., Sher, Lawrence D., Shreffler, Wayne G., Sindher, Sayantani B., Stillerman, Allan, Wood, Robert, Yang, William H., Bois, Timothée, Sampson, Hugh A., and Bégin, Philippe

Published
2022
Full Text
View/download PDF

12. Dupilumab Reduces Oral Corticosteroid Use in Patients With Corticosteroid-Dependent Severe Asthma: An Analysis of the Phase 3, Open-Label Extension TRAVERSE Trial

Author

Sher, Lawrence D., Wechsler, Michael E., Rabe, Klaus F., Maspero, Jorge F., Daizadeh, Nadia, Mao, Xuezhou, Ortiz, Benjamin, Mannent, Leda P., Laws, Elizabeth, Ruddy, Marcella, Pandit-Abid, Nami, Jacob-Nara, Juby A., Gall, Rebecca, Rowe, Paul J., Deniz, Yamo, Lederer, David J., and Hardin, Megan

Published
2022
Full Text
View/download PDF

13. Safety and immunogenicity of an AS03-adjuvanted SARS-CoV-2 recombinant protein vaccine (CoV2 preS dTM) in healthy adults: interim findings from a phase 2, randomised, dose-finding, multicentre study

Author

Sridhar, Saranya, Joaquin, Arnel, Bonaparte, Matthew I, Bueso, Agustin, Chabanon, Anne-Laure, Chen, Aiying, Chicz, Roman M, Diemert, David, Essink, Brandon J, Fu, Bo, Grunenberg, Nicole A, Janosczyk, Helene, Keefer, Michael C, Rivera M, Doris M, Meng, Ya, Michael, Nelson L, Munsiff, Sonal S, Ogbuagu, Onyema, Raabe, Vanessa N, Severance, Randall, Rivas, Enrique, Romanyak, Natalya, Rouphael, Nadine G, Schuerman, Lode, Sher, Lawrence D, Walsh, Stephen R, White, Judith, von Barbier, Dalia, de Bruyn, Guy, Canter, Richard, Grillet, Marie-Helene, Keshtkar-Jahromi, Maryam, Koutsoukos, Marguerite, Lopez, Denise, Masotti, Roger, Mendoza, Sandra, Moreau, Catherine, Ceregido, Maria Angeles, Ramirez, Shelly, Said, Ansoyta, Tavares-Da-Silva, Fernanda, Shi, Jiayuan, Tong, Tina, Treanor, John, Diazgranados, Carlos A, and Savarino, Stephen

Published
2022
Full Text
View/download PDF

14. Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1–2, dose-ranging study

Author

Goepfert, Paul A, Fu, Bo, Chabanon, Anne-Laure, Bonaparte, Matthew I, Davis, Matthew G, Essink, Brandon J, Frank, Ian, Haney, Owen, Janosczyk, Helene, Keefer, Michael C, Koutsoukos, Marguerite, Kimmel, Murray A, Masotti, Roger, Savarino, Stephen J, Schuerman, Lode, Schwartz, Howard, Sher, Lawrence D, Smith, Jon, Tavares-Da-Silva, Fernanda, Gurunathan, Sanjay, DiazGranados, Carlos A, and de Bruyn, Guy

Published
2021
Full Text
View/download PDF

16. Continuous and Daily Oral Immunotherapy for Peanut Allergy: Results from a 2-Year Open-Label Follow-On Study

Author

Vickery, Brian P., Vereda, Andrea, Nilsson, Caroline, du Toit, George, Shreffler, Wayne G., Burks, A. Wesley, Jones, Stacie M., Fernández-Rivas, Montserrat, Blümchen, Katharina, O’B. Hourihane, Jonathan, Beyer, Kirsten, Anagnostou, Aikaterini, Assa’ad, Amal H., Ben-Shoshan, Moshe, Bird, J. Andrew, Carr, Tara F., Carr, Warner W., Casale, Thomas B., Chong, Hey Jin, Ciaccio, Christina E., Dorsey, Morna J., Fineman, Stanley M., Fritz, Stephen B., Greiner, Alexander N., Greos, Leon S., Hampel, Frank C., Jr., Ibáñez, Maria Dolores, Jeong, David K., Johnston, Douglas T., Kachru, Rita, Kim, Edwin H., Lanser, Bruce J., Leonard, Stephanie A., Maier, Mary C., Mansfield, Lyndon E., Muraro, Antonella, Ohayon, Jason A., Oude Elberink, Joanna N.G., Petroni, Daniel H., Pongracic, Jacqueline A., Portnoy, Jay M., Rachid, Rima, Rupp, Ned T., Sanders, Georgiana M., Sharma, Hemant P., Sharma, Vibha, Sher, Ellen R., Sher, Lawrence, Sindher, Sayantani B., Siri, Dareen, Spergel, Jonathan M., Sprikkelman, Aline B., Sussman, Gordon L., Tsoumani, Marina, Varshney, Pooja, Vitalpur, Girish, Wang, Julie, Yang, William H., Zubeldia, José Manuel, Smith, Alex, Ryan, Robert, and Adelman, Daniel C.

Published
2021
Full Text
View/download PDF

17. Dupilumab Improves Asthma and Sinonasal Outcomes in Adults with Moderate to Severe Atopic Dermatitis

Author

Boguniewicz, Mark, Beck, Lisa A., Sher, Lawrence, Guttman-Yassky, Emma, Thaçi, Diamant, Blauvelt, Andrew, Worm, Margitta, Corren, Jonathan, Soong, Weily, Lio, Peter, Rossi, Ana B., Lu, Yufang, Chao, Jingdong, Eckert, Laurent, Gadkari, Abhijit, Hultsch, Thomas, Ruddy, Marcella, Mannent, Leda P., Graham, Neil M.H., Pirozzi, Gianluca, Chen, Zhen, and Ardeleanu, Marius

Published
2021
Full Text
View/download PDF

19. Dupilumab Efficacy in Uncontrolled, Moderate-to-Severe Asthma with Self-Reported Chronic Rhinosinusitis

Author

Maspero, Jorge F., Katelaris, Constance H., Busse, William W., Castro, Mario, Corren, Jonathan, Chipps, Bradley E., Peters, Anju T., Pavord, Ian D., Ford, Linda B., Sher, Lawrence, Rabe, Klaus F., Rice, Megan S., Rowe, Paul, Lu, Yufang, Harel, Sivan, Jagerschmidt, Alexandre, Khan, Asif H., Kamat, Siddhesh, Pirozzi, Gianluca, Amin, Nikhil, Ruddy, Marcella, Graham, Neil M.H., Mannent, Leda P., and Teper, Ariel

Published
2020
Full Text
View/download PDF

20. 385. Safety and Immunogenicity of a Variant-adapted Bivalent (Original/Omicron BA.4/BA.5) BNT162b2 COVID-19 Vaccine Given as a Booster (Dose 4) to 5- to 11-Year-Old Children Who Previously Received 3 Doses of Original BNT162b2

Author

Paulsen, Grant C, primary, Sher, Lawrence, additional, Sabharwal, Charu, additional, Kitchin, Nicholas, additional, Hill, Sungeen, additional, Wasserman, Emily, additional, Xu, Xia, additional, Maldonado, Yvonne A, additional, Barnett, Elizabeth, additional, Englund, Janet A, additional, Walter, Emmanuel, additional, Munoz, Flor M, additional, Simoes, Eric, additional, Talaat, Kawsar R, additional, Kamidani, Satoshi, additional, Moyer, Lisa, additional, Parikh, Vrunda, additional, Ma, Hua, additional, Wang, Xingbin, additional, Koury, Kenneth, additional, Anderson, Annaliesa S, additional, Swanson, Kena A, additional, Gurtman, Alejandra C, additional, and Gruber, William C, additional

Published
2023
Full Text
View/download PDF

21. 362. Safety and Immunogenicity of a Variant-adapted Bivalent (Original/Omicron BA.4/BA.5) BNT162b2 COVID-19 Vaccine Given as a Booster (Dose 4) to Toddlers and Children 6 Months to < 5 Years of Age Who Previously Received Original BNT162b2 as a 3-Dose Primary Series

Author

Sher, Lawrence, primary, Sabharwal, Charu, additional, Kitchin, Nicholas, additional, Kofi Boakya-Appiah, Justice, additional, Xu, Xia, additional, Walter, Emmanuel, additional, Maldonado, Yvonne A, additional, Munoz, Flor M, additional, Englund, Janet A, additional, Talaat, Kawsar R, additional, Senders, Shelly, additional, Kamidani, Satoshi, additional, Barnett, Elizabeth, additional, Paulsen, Grant C, additional, Moyer, Lisa, additional, Parikh, Vrunda, additional, Ma, Hua, additional, Wang, Xingbin, additional, Koury, Kenneth, additional, Anderson, Annaliesa S, additional, Swanson, Kena A, additional, Gurtman, Alejandra C, additional, and Gruber, William C, additional

Published
2023
Full Text
View/download PDF

22. Phase 2b Randomized Trial of OX40 Inhibitor Telazorlimab for Moderate-to-Severe Atopic Dermatitis

Author

Rewerska, Barbara, primary, Sher, Lawrence D., additional, Alpizar, Sady, additional, Pauser, Sylvia, additional, Pulka, Grazyna, additional, Mozaffarian, Neelufar, additional, Salhi, Yacine, additional, Martinet, Camille, additional, Jabert, Wafaa, additional, Gudi, Girish, additional, CA, Vinu, additional, GN, Sunitha, additional, Macoin, Julie, additional, Anstett, Victor, additional, Turrini, Riccardo, additional, Doucey, Marie-Agnès, additional, Blein, Stanislas, additional, Konto, Cyril, additional, and Machkova, Martina, additional

Published
2023
Full Text
View/download PDF

23. Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study

Author

Dayan, Gustavo H., primary, Rouphael, Nadine, additional, Walsh, Stephen R., additional, Chen, Aiying, additional, Grunenberg, Nicole, additional, Allen, Mary, additional, Antony, Johannes, additional, Bhate, Amit Suresh, additional, Beresnev, Tatiana, additional, Bonaparte, Matthew I., additional, Celle, Médéric, additional, Ceregido, Maria Angeles, additional, Corey, Lawrence, additional, Fu, Bo, additional, Grillet, Marie-Helene, additional, Keshtkar-Jahromi, Maryam, additional, Juraska, Michal, additional, Kee, Jia Jin, additional, Kaali, Seyram, additional, Koutsoukos, Marguerite, additional, Masotti, Roger, additional, Michael, Nelson L., additional, Neuzil, Kathleen M., additional, Reynales, Humberto, additional, Robb, Merlin L., additional, Uchiyama, Akiyoshi, additional, Sawe, Fredrick, additional, Schuerman, Lode, additional, Shrestha, Rajeev, additional, Tong, Tina, additional, Treanor, John, additional, Diazgranados, Carlos A., additional, Chicz, Roman M., additional, Gurunathan, Sanjay, additional, Savarino, Stephen, additional, Sridhar, Saranya, additional, Abalos, Karina, additional, Adams, Michael, additional, Allaw, Mohamed, additional, Aloysia, Naveena, additional, Amuasi, John Humphrey, additional, Ansah, Nana Akosua, additional, Asante, Kwaku Poku, additional, Benkeser, David, additional, Berge, Aude, additional, Breuer, Thomas, additional, Briesemeister, Liz, additional, Broder, Gail, additional, Bonfanti, Alberto Cadena, additional, Calinescu, Cornell, additional, Canter, Richard, additional, Carrillo, Jaime Augusto, additional, Chansinghakul, Danaya, additional, Coux, Florence, additional, Das, Chandan, additional, Davies, Matthew, additional, Devlin, Louis, additional, Fay, Michael, additional, Follmann, Dean, additional, Frago, Carina, additional, Fukase, Hiroyuki, additional, Garinga, Agnes, additional, Gilbert, Peter B., additional, Gonzalez, Claudia, additional, Granados, Maria Angelica, additional, Greiwe, Cathy, additional, Guillery, Lea, additional, Hall, Jessicalee, additional, Henderson, Jeffrey, additional, Huang, Ying, additional, Hudzina, Kathy, additional, Hural, John, additional, Hutchens, Mark, additional, Jain, Manish, additional, Jennings, William, additional, Kanodia, Piush, additional, Kimmel, Murray, additional, Kirby, William, additional, Khandelwal, Nitin, additional, Kopp, James, additional, Kosolsak, Chalit, additional, Kublin, Jim, additional, Kukian, Darshna, additional, Kushwaha, Jitendra Singh, additional, Laot, Thelma, additional, Lopez-Medina, Eduardo, additional, Arroyo, Hugo Macareno, additional, Mamod, Stephanie, additional, Mangarule, Somnath, additional, Martin, Troy, additional, Menard, Lisa, additional, Mendoza, Sandra, additional, Meyer, Robert, additional, Middleton, Randle, additional, Miracle, Jill, additional, Mizuyama, Kazuyuki, additional, Mohapatra, Satyajit, additional, Moreau, Catherine, additional, Murray, Linda, additional, Nagamatsu, Shinya, additional, Newberg, Joseph, additional, Noriega, Fernando, additional, Nugent, Paul, additional, Peake-Andrasik, Michele, additional, Pekala, David, additional, Peng, Penny, additional, Py, Marie-Laure, additional, Ramirez, Shelly, additional, Reddy, Chinthaparthi Prabhakar, additional, Reynolds, Michelle, additional, Rivas, Enrique, additional, Sater, Nessryne, additional, Shah, Jinen, additional, Sher, Lawrence, additional, Sieger, Silva, additional, Singh, Chandramani, additional, Singh, Veer Bahadur, additional, Sirisuphmitr, Nuchra, additional, Starkey, Thomas, additional, Suzuki, Kazuo, additional, Tamrakar, Dipesh, additional, Tangemen, Cayce, additional, Da-Silva, Fernanda Tavares, additional, Taylor, David, additional, Tharenos, Leslie, additional, Wartel, T. Anh, additional, Zaworski, Elodie, additional, and Zhang, Nianxian, additional

Published
2023
Full Text
View/download PDF

24. DUPILUMAB REDUCES RESCUE SYSTEMIC CORTICOSTEROID USE IN CHILDREN WITH UNCONTROLLED MODERATE TO SEVERE ASTHMA REGARDLESS OF PRIOR EXACERBATION HISTORY

Author

GALL, REBECCA, primary, DUCHARME, FRANCINE M, additional, SHER, LAWRENCE D, additional, HAMELMANN, ECKARD, additional, DE MIR-MESSA, INES, additional, XIA, CHANGMING, additional, LEDANOIS, OLIVIER, additional, JACOB-NARA, JUBY A, additional, SACKS, HARRY, additional, ROWE, PAUL J, additional, and DENIZ, YAMO, additional

Published
2023
Full Text
View/download PDF

25. Efficacy of dupilumab in patients with uncontrolled, moderate‐to‐severe asthma with fungal sensitization

Author

Corren, Jonathan, primary, Hanania, Nicola A., additional, Busse, William W., additional, Sher, Lawrence D., additional, Altincatal, Arman, additional, Hardin, Megan, additional, Mannent, Leda P., additional, Amin, Nikhil, additional, Lederer, David J., additional, Soler, Xavier, additional, Jacob‐Nara, Juby A., additional, Rowe, Paul J., additional, and Deniz, Yamo, additional

Published
2023
Full Text
View/download PDF

26. Dupilumab reduces systemic corticosteroid exposure in children with uncontrolled moderate-to-severe asthma regardless of prior exacerbations

Author

Hamelmann, Eckard, primary, Deschildre, Antoine, additional, Ducharme, Francine M., additional, Sher, Lawrence D., additional, De Mir, Ines, additional, Xia, Changming, additional, Gall, Rebecca, additional, Ledanois, Olivier, additional, Jacob-Nara, Juby A., additional, Sacks, Harry, additional, Rowe, Paul J., additional, and Deniz, Yamo, additional

Published
2023
Full Text
View/download PDF

27. Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis

Author

Beck, Lisa A., Thaçi, Diamant, Deleuran, Mette, Blauvelt, Andrew, Bissonnette, Robert, de Bruin-Weller, Marjolein, Hide, Michihiro, Sher, Lawrence, Hussain, Iftikhar, Chen, Zhen, Khokhar, Faisal A., Beazley, Bethany, Ruddy, Marcella, Patel, Naimish, Graham, Neil M. H., Ardeleanu, Marius, and Shumel, Brad

Published
2020
Full Text
View/download PDF

28. Equity: Ownership by Minorities and Women of Research Projects.

Author

Wilkinson, Patricia and Sher, Lawrence

Abstract

Beginning in 1987, a reform movement was heavily funded by the National Science Foundation (NSF) to change the teaching of calculus. Borough of Manhattan Community College (BMCC) received seven NSF grants over an eight-year period, allowing the college to: establish a state-of-the-art calculus computer lab; purchase calculators, graphing calculators, and laptops; send selected faculty to workshops and run workshops for faculty; and hire half-time college lab technicians and support staff. This paper presents results of an assessment of how BMCC's students feel about themselves in pre-calculus and calculus classes and, in particular, how they feel about the use of computers, graphing calculators, working in groups, and creating written research projects and portfolios of their work. Students were asked, through a questionnaire and interviews, on a scale of one to five, how strongly they agreed with 15 statements; comments were also solicited. Data were analyzed for the whole cohort and then by gender to see if women responded differently than men. Results are discussed for each of the 15 statements, and student comments are reproduced. One implication of the study is that there needs to be increased sensitivity in order to make women equal partners in the classroom and laboratory. (AEF)

Published
1999

29. New Federal Ban Prohibits TikTok On Devices Used On Government Contracts

Author

Sher, Lawrence S

Subjects
Government contractors -- Laws, regulations and rules, Online social networks -- Laws, regulations and rules, Government regulation, Business, international, TikTok (Online social network) -- Laws, regulations and rules
Abstract

On June 2, 2023, the Federal Government issued a new Federal Acquisition Regulation (FAR) clause, FAR 52.204-27, the No TikTok on Government Devices Act,1 which prohibits the presence or use [...]

Published
2023

31. Student Created Calculus Movies Using Computers and the TI-92.

Author

Sher, Lawrence and Wilkinson, Patricia

Abstract

The Mathematics Department at Borough of Manhattan Community College (BMCC) (New York) has been actively involved since 1988 in a serious and successful program to improve instruction, understanding, and retention for women and minority students in calculus courses. One result of this work has been students creating calculus animations using computers. This paper reports on a workshop that had participants create projects and animations on the TI-92 calculator. The two projects presented here are an economics project that can effectively exploit the classroom use of the new TI-92 calculator and an animation of the MacLaurin series for Sin(x). Steps to create animations using the TI-92 are also included. (JRH)

Published
1996

32. Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trial

Author

Chouinard, Guy, FitzGerald, J Mark, Rostami, Maryam, Oosthuizen, Jean, Pek, Bonavuth, Patel, Deepen, Houle, Pierre-Alain, Laviolette, Michel, Khattak, Sohail, Killorn, Patrick, Keller, Claus, Schenkenberger, Isabelle, Zielen, Stefan, Ballenberger, Sabine, Hoffmann, Martin, Kirschner, Joachim, Papp, Márta, Kecskés, Teréz, Póczi, Magdolna, Molnár, Lajos, Radeczky, Éva, Schlezák, Judit, Springer, Ewa, Balicka, Violetta, Kaczmarek, Jadwiga, Madra-Rogacka, Danuta, Pisarczyk-Bogacka, Ewa, Zurowska-Gebala, Malgorzata, Marczak, Maciej, Napora, Piotr, Pomiecko, Witold, Pribulova, Erika, Kurthova, Svetlana, Drugdova, Maria, Kavkova, Denisa, Frajtova, Luboslava, Golubov, Alexander, Paulinyova, Dagmar, Hasicova, Daniela, Michalickova, Miriam, Trevino, Miguel, Campbell, Charles, Wachtel, Andrew, Bleecker, Eugene, LaForce, Craig, Bernstein, David, Spangenthal, Selwyn, Kerwin, Edward, Mansfield, Lyndon, Ratner, Paul, Arora, Samir, Feldman, Gregory, Okwara, Benedict, Cruz, Humberto, Sher, Lawrence, Pedinoff, Andrew, Corder, Clinton, Ferguson, Gary T, Bleecker, Eugene R, Barker, Peter, Wu, Yanping, Jison, Maria, and Goldman, Mitchell

Published
2017
Full Text
View/download PDF

33. Dupilumab long-term efficacy in patients with non–OCS–dependent asthma with and without evidence of allergic asthma.

Author

Sher, Lawrence D., Corren, Jonathan, Pavord, Ian D., Daizadeh, Nadia, Altincatal, Arman, Soler, Xavier, Djandji, Michel, Radwan, Amr, Jacob-Nara, Juby A., Deniz, Yamo, and Rowe, Paul J.

Subjects
*ASTHMATICS, *DUPILUMAB, *ASTHMA, *FORCED expiratory volume, *WHEEZE
Abstract

The open-label extension TRAVERSE study (NCT02134028) assessed dupilumab long-term safety and efficacy in patients who completed Phase 2/3 dupilumab asthma studies. This post hoc analysis evaluated long-term efficacy in type 2 patients with and without evidence of allergic asthma who enrolled in TRAVERSE from Phase 3 QUEST (NCT02414854) and Phase 2b (NCT01854047) studies. Non–type 2 patients with evidence of allergic asthma were also assessed. Unadjusted annualized exacerbation rates during parent study and TRAVERSE treatment period, and changes from parent study baseline in pre-bronchodilator forced expiratory volume in 1 s (FEV1) and in 5-item Asthma Control Questionnaire (ACQ-5) scores were assessed in patients from QUEST and Phase 2b; change from parent study baseline in total IgE level was assessed in patients enrolled from Phase 2b. 2062 patients from Phase 2b and QUEST enrolled in TRAVERSE. Of these, 969 were type 2 with evidence of allergic asthma; 710 were type 2 without evidence of allergic asthma; and 194 were non–type 2 with evidence of allergic asthma at parent study baseline. In these populations, reductions in exacerbation rates observed during parent studies were sustained during TRAVERSE. Type 2 patients who switched from placebo arm to dupilumab in TRAVERSE experienced similar reductions in severe exacerbation rates, and improvements in lung function and asthma control to those patients who already received dupilumab during the parent study. Dupilumab efficacy was sustained for up to 3 years in patients with uncontrolled, moderate-to-severe type 2 inflammatory asthma, with or without evidence of allergic asthma. ClinicalTrials.gov identifier: NCT02134028 [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

34. Evaluation of BNT162b2 Covid-19 Vaccine in Children Younger than 5 Years of Age

Author

Muñoz, Flor M., primary, Sher, Lawrence D., additional, Sabharwal, Charu, additional, Gurtman, Alejandra, additional, Xu, Xia, additional, Kitchin, Nicholas, additional, Lockhart, Stephen, additional, Riesenberg, Robert, additional, Sexter, Joanna M., additional, Czajka, Hanna, additional, Paulsen, Grant C., additional, Maldonado, Yvonne, additional, Walter, Emmanuel B., additional, Talaat, Kawsar R., additional, Englund, Janet A., additional, Sarwar, Uzma N., additional, Hansen, Caitlin, additional, Iwamoto, Martha, additional, Webber, Chris, additional, Cunliffe, Luke, additional, Ukkonen, Benita, additional, Martínez, Silvina N., additional, Pahud, Barbara A., additional, Munjal, Iona, additional, Domachowske, Joseph B., additional, Swanson, Kena A., additional, Ma, Hua, additional, Koury, Kenneth, additional, Mather, Susan, additional, Lu, Claire, additional, Zou, Jing, additional, Xie, Xuping, additional, Shi, Pei-Yong, additional, Cooper, David, additional, Türeci, Özlem, additional, Şahin, Uğur, additional, Jansen, Kathrin U., additional, and Gruber, William C., additional

Published
2023
Full Text
View/download PDF

37. Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study

Author

Menzies-Gow, Andrew, primary, Wechsler, Michael E, additional, Brightling, Christopher E, additional, Korn, Stephanie, additional, Corren, Jonathan, additional, Israel, Elliot, additional, Chupp, Geoffrey, additional, Bednarczyk, Artur, additional, Ponnarambil, Sandhia, additional, Caveney, Scott, additional, Almqvist, Gun, additional, Gołąbek, Monika, additional, Simonsson, Linda, additional, Lawson, Kaitlyn, additional, Bowen, Karin, additional, Colice, Gene, additional, Hetzel, Jorge Lima, additional, Fiterman, Jussara, additional, Souza Machado, Adelmir, additional, Antila, Martti Anton, additional, Lima, Marina Andrade, additional, Minamoto, Suzana Erico Tanni, additional, Blanco, Daniela Cavalet, additional, Bezerra, Patricia Gomes de Matos, additional, Houle, Pierre-Alain, additional, Lemiere, Catherine, additional, Melenka, Lyle S, additional, Leigh, Richard, additional, Mitchell, Patrick, additional, Anees, Syed, additional, Pek, Bonavuth, additional, Chouinard, Guy, additional, Cheema, Amarjit S, additional, Yang, William Ho-Ching, additional, Philteos, George, additional, Chanez, Pascal, additional, Bourdin, Arnaud, additional, Devouassoux, Gilles, additional, Taille, Camille, additional, De Blay, Frédéric, additional, Leroyer, Christophe, additional, Beurnier, Antoine, additional, Garcia, Gilles, additional, Girodet, Pierre-Olivier, additional, Blanc, François-Xavier, additional, Magnan, Antoine, additional, Wanin, Stéphanie, additional, Just, Jocelyne, additional, Linde, Richard, additional, Zielen, Stefan, additional, Förster, Karin, additional, Geßner, Christian, additional, Jandl, Margret, additional, Buhl, Roland Otto, additional, Kornmann, Marc Oliver, additional, Linnhoff, Anneliese, additional, Ludwig-Sengpiel, Andrea, additional, Ehlers, Martin, additional, Schmoller, Tibor, additional, Steffen, Heiner, additional, Hoffmann, Martin, additional, Kirschner, Joachim, additional, Schmidt, Olaf, additional, Welte, Tobias, additional, Temme, Hilke, additional, Wand, Ori, additional, Bar-Shai, Amir, additional, Izbicki, Gabriel, additional, Berkman, Neville, additional, Fink, Gershon, additional, Shitrit, David, additional, Adir, Yochai, additional, Kuna, Piotr, additional, Rewerska, Barbara, additional, Pisarczyk-Bogacka, Ewa, additional, Kurbacheva, Oksana, additional, Mikhailov, Sergey L, additional, Vasilev, Maksim, additional, Emelyanov, Alexander, additional, Wali, Siraj, additional, Albanna, Amr, additional, van Zyl-Smit, Richard, additional, Abdullah, Ismail, additional, Bernhardi, David, additional, Hoosen, Farzana, additional, Irusen, Elvis, additional, Kalla, Ismail, additional, Lakha, Deepak, additional, Mitha, Essack, additional, Naidoo, Visvakuren, additional, Nell, Haylene, additional, Padayachee, Trevenesan, additional, Reddy, Jeevren, additional, Petrick, Friedrich, additional, van der Walt, Eugene, additional, Vawda, Zubar Fazal Ahmed, additional, Park, Hae-Sim, additional, Lee, Sang Haak, additional, Kim, Mi-Kyeong, additional, Park, Jung-Won, additional, Cho, You Sook, additional, Lee, Byung Jae, additional, Chang, Yoon-Seok, additional, Park, Choon-Sik, additional, Lee, Kwan Ho, additional, Lee, Sook Young, additional, Yoon, HyoungKyu, additional, Sohn, Kyoung Hee, additional, Park, Myung Jae, additional, Min, Kyung Hoon, additional, Cho, Young Joo, additional, Park, Han Ki, additional, Lee, YongChul, additional, Lee, Jaechun, additional, Sheu, Chau-Chyun, additional, Tu, Chih-Yen, additional, Lee, Kang-Yun, additional, Bavbek, Sevim, additional, Gemicioglu, Bilun, additional, Ediger, Dane, additional, Kalkan, Ilkay Koca, additional, Makieieva, Nataliia, additional, Ostrovskyy, Mykola, additional, Dytyatkovs'ka, Yevgeniya, additional, Mostovoy, Yuriy Mykhaylovych, additional, Lebed, Kyrylo, additional, Yakovenko, Oleh, additional, Adams, Atoya, additional, Mooring, Timothy, additional, Torres Jr, Louis, additional, Sexton, Marvin, additional, Thompson, Ernest, additional, Bernstein, Jonathan A, additional, Lisi, Paul, additional, Chappel, Christopher M, additional, Cole, Jeremy, additional, Greenwald, Gary I, additional, Jones, Conigliaro, additional, Klein, Ryan Mitchell, additional, Pham, David N, additional, Spangenthal, Selwyn, additional, Weinstein, Steven F, additional, Windom, Hugh H, additional, Kao, Neil L, additional, Leong, Mila A, additional, Mehta, Vinay, additional, Moore, Wendy C, additional, Bhat, Saligrama, additional, Aish, Bassil, additional, Meltzer, Steven M, additional, Moss, Mark H, additional, Kerwin, Edward M, additional, Delgado, John Palsted, additional, Lucksinger, Gregg Hudson, additional, Thompson, Charles A, additional, Alpizar, Sady A, additional, Vadgama, Sanjay Virgi, additional, Zafar, Zahid, additional, Jacobs, Joshua S, additional, Lugogo, NJira, additional, Jain, Neal, additional, Sher, Lawrence D, additional, Andrawis, Nabil S, additional, Fuentes, David, additional, Boren, Eric Jason, additional, Gonzalez, Erika G, additional, Talreja, Neetu, additional, Durrani, Sheharyar Sandy, additional, Sekhsaria, Sudhir, additional, DeLeon, Samuel, additional, Shukla, Mayank, additional, Totszollosy Tarpay, Martha M, additional, Fakih, Faisal, additional, Hudes, Golda, additional, Tillinghast, Jeffrey P, additional, Korenblat, Phillip E, additional, Shenoy, Kartik, additional, Que, Loretta, additional, Kureishy, Shahrukh Ahmad, additional, Umeh, Fred Chukwuemeka, additional, Nguyen, Vinh Nhu, additional, Chu, Hanh Thi, additional, and Nguyen, Thuy Thi Dieu, additional

Published
2023
Full Text
View/download PDF

38. Participant characteristics and safety outcomes of peanut oral immunotherapy in the RAMSES and ARC011 trials

Author

Ciaccio, Christina, primary, Goldsobel, Alan B., additional, Anagnostou, Aikaterini, additional, Beyer, Kirsten, additional, Casale, Thomas B., additional, Deschildre, Antoine, additional, Fernández-Rivas, Montserrat, additional, Hourihane, Jonathan O'B., additional, Krawiec, Marta, additional, Lieberman, Jay, additional, Scurlock, Amy M., additional, Vickery, Brian P., additional, Smith, Alex, additional, Tilles, Stephen A., additional, Adelman, Daniel C., additional, Brown, Kari R., additional, Assa'ad, Amal H., additional, Bernstein, David I., additional, Bird, J. Andrew, additional, Carr, Tara F., additional, Carr, Warner W., additional, Cheema, Amarjit S., additional, Corren, Jonathan, additional, Darter, Amy Liebl, additional, Dorsey, Morna J., additional, Fineman, Stanley M., additional, Fleischer, David M., additional, Fritz, Stephen B., additional, Gogate, Shaila U., additional, Greiner, Alexander N., additional, Hampel, Frank C., additional, Jacobs, Joshua S., additional, Jain, Sanjeev, additional, Jarvinen-Seppo, Kirsi, additional, Jeong, David K., additional, Johnston, Douglas T., additional, Kachru, Rita, additional, Kim, Edwin H., additional, Koleilat, Majed, additional, Lanser, Bruce J., additional, Leonard, Stephanie A., additional, Maier, Mary C., additional, Manning, Michael E., additional, Mansfield, Lyndon E., additional, Matz, Jonathan, additional, Nadeau, Kari, additional, Ohayon, Jason A., additional, Perez, Elena, additional, Petroni, Daniel H., additional, Pollard, Stephen J., additional, Ponda, Punita, additional, Portnoy, Jay M., additional, Rachid, Rima, additional, Ratner, Paul H., additional, Robison, Rachel, additional, Rupp, Ned T., additional, Sanders, Georgiana M., additional, Sharma, Hemant P., additional, Sher, Ellen R., additional, Sher, Lawrence D., additional, Sher, Mandel, additional, Shreffler, Wayne G., additional, Siri, Dareen D., additional, Skolnick, Helen S., additional, Soong, Weily, additional, Soteres, Daniel F., additional, Spergel, Jonathan M., additional, Stillerman, Allan, additional, Sussman, Gordon L., additional, Tam, Jonathan, additional, Varshney, Pooja, additional, Waserman, Susan, additional, Windom, Hugh H., additional, Wood, Robert, additional, and Yang, William H., additional

Published
2022
Full Text
View/download PDF

39. The long-term effect of dupilumab on dyspnea, sleep, and activity in oral corticosteroid-dependent severe asthma

Author

Sher, Lawrence D., primary, Passalacqua, Giovanni, additional, Taillé, Camille, additional, Cohn, Lauren, additional, Daizadeh, Nadia, additional, Pandit-Abid, Nami, additional, Soler, Xavier, additional, Khodzhayev, Angela, additional, Jacob-Nara, Juby A., additional, Deniz, Yamo, additional, Rowe, Paul J., additional, Nag, Arpita, additional, and Zhang, Yi, additional

Published
2022
Full Text
View/download PDF

40. Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial

Author

Paller, Amy S, primary, Simpson, Eric L, additional, Siegfried, Elaine C, additional, Cork, Michael J, additional, Wollenberg, Andreas, additional, Arkwright, Peter D, additional, Soong, Weily, additional, Gonzalez, Mercedes E, additional, Schneider, Lynda C, additional, Sidbury, Robert, additional, Lockshin, Benjamin, additional, Meltzer, Steven, additional, Wang, Zhixiao, additional, Mannent, Leda P, additional, Amin, Nikhil, additional, Sun, Yiping, additional, Laws, Elizabeth, additional, Akinlade, Bolanle, additional, Dillon, Myles, additional, Kosloski, Matthew P, additional, Kamal, Mohamed A, additional, Dubost-Brama, Ariane, additional, Patel, Naimish, additional, Weinreich, David M, additional, Yancopoulos, George D, additional, O’Malley, John T, additional, Bansal, Ashish, additional, Pepper, Amber, additional, Paller, Amy S, additional, Cohen, David, additional, Pariser, David, additional, Leflein, Jeffrey, additional, Weinberg, Jeffrey, additional, Browning, John, additional, Teng, Joyce, additional, Wine Lee, Lara, additional, Sher, Lawrence, additional, Diaz, Lucia, additional, Schneider, Lynda, additional, Rupp, Ned, additional, Ong, Peck, additional, Cartwright, Robert, additional, Pinter, Andreas, additional, Schnopp, Christina, additional, Korkosz, Anna, additional, Bystrzanowska, Dorota, additional, Sygula, Ewa, additional, Zdybski, Jacek, additional, and Padlewska, Kamila, additional

Published
2022
Full Text
View/download PDF

41. A Classroom Note on Generating Examples for the Laws of Sines and Cosines from Pythagorean Triangles

Author

Sher, Lawrence and Sher, David

Abstract

By selecting certain special triangles, students can learn about the laws of sines and cosines without wrestling with long decimal representations or irrational numbers. Since the law of cosines requires only one of the three angles of a triangle, there are many examples of triangles with integral sides and a cosine that can be represented exactly by a value that is only a one or two place decimal. The law of sines involves at least two angles of a triangle, and integer-sided triangles that have two angles with sines represented by one or two decimal places are rare, but the authors found several. These examples can help students better understand these trigonometric laws. (Contains 5 tables and 1 figure.)

Published
2007

42. Baseline Clinical and Immunologic Characteristics of Children Screened in the Peanut Oral Immunotherapy Study of Early Intervention for Desensitization (POSEIDON) Trial

Author

Vickery, Brian, primary, du Toit, George, additional, Ratnayake, Anoshie, additional, Blumchen, Katharina, additional, Sharma, Vibha, additional, Chapman, John, additional, Deschildre, Antoine, additional, Sher, Lawrence, additional, Norval, David, additional, Adelman, Daniel, additional, Beyer, Kirsten, additional, Casale, Thomas, additional, Greiner, Alexander, additional, Cox, Amanda, additional, Robison, Rachel, additional, Brown, Kari, additional, and Scurlock, Amy, additional

Published
2022
Full Text
View/download PDF

43. Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma

Author

Bacharier, Leonard B., primary, Maspero, Jorge F., additional, Katelaris, Constance H., additional, Fiocchi, Alessandro G., additional, Gagnon, Remi, additional, de Mir, Ines, additional, Jain, Neal, additional, Sher, Lawrence D., additional, Mao, Xuezhou, additional, Liu, Dongfang, additional, Zhang, Yi, additional, Khan, Asif H., additional, Kapoor, Upender, additional, Khokhar, Faisal A., additional, Rowe, Paul J., additional, Deniz, Yamo, additional, Ruddy, Marcella, additional, Laws, Elizabeth, additional, Patel, Naimish, additional, Weinreich, David M., additional, Yancopoulos, George D., additional, Amin, Nikhil, additional, Mannent, Leda P., additional, Lederer, David J., additional, and Hardin, Megan, additional

Published
2021
Full Text
View/download PDF

44. Flight Simulator: Use of SpaceGraph Display in an Instructor/Operator Station. Final Report.

Author

Bolt, Beranek and Newman, Inc., Cambridge, MA. and Sher, Lawrence D.

Abstract

This report describes SpaceGraph, a new computer-driven display technology capable of showing space-filling images, i.e., true three dimensional displays, and discusses the advantages of this technology over flat displays for use with the instructor/operator station (IOS) of a flight simulator. Ideas resulting from 17 brainstorming sessions with pilots, instructor pilots, supervisors of pilot training, researchers in pilot training, and experts in human factors related to flying are outlined chronologically by meeting number. Concepts involved in these suggestions are discussed, and a brief discussion of priorities for future development concludes the report. Details of the time-varying, very-wide-field-of-view optics used are appended. (MER)

Published
1981

45. Safety and immunogenicity of a SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in healthy adults: interim findings from a phase 2, randomised, dose-finding, multi-centre study

Author

Sridhar, Saranya, primary, Joaquin, Arnel, additional, Bonaparte, Matthew I, additional, Bueso, Agustin, additional, Chabanon, Anne-Laure, additional, Chen, Aiying, additional, Chicz, Roman M., additional, Diemert, David, additional, Essink, Brandon J, additional, Fu, Bo, additional, Grunenberg, Nicole A, additional, Janosczyk, Helene, additional, Keefer, Michael C, additional, Rivera M, Doris M, additional, Meng, Ya, additional, Michael, Nelson L., additional, Munsiff, Sonal S, additional, Ogbuagu, Onyema, additional, Raabe, Vanessa N, additional, Severance, Randall, additional, Rivas, Enrique, additional, Romanyak, Natalya, additional, Rouphael, Nadine G, additional, Schuerman, Lode, additional, Sher, Lawrence D, additional, Walsh, Stephen R, additional, White, Judith, additional, von Barbier, Dalia, additional, de Bruyn, Guy, additional, Canter, Richard, additional, Grillet, Marie-Helene, additional, Keshtkar-Jahromi, Maryam, additional, Koutsoukos, Marguerite, additional, Lopez, Denise, additional, Masotti, Roger, additional, Mendoza, Sandra, additional, Moreau, Catherine, additional, Ceregido, Maria Angeles, additional, Ramirez, Shelly, additional, Said, Ansoyta, additional, Tavares-Da-Silva, Fernanda, additional, Shi, Jiayuan, additional, Tong, Tina, additional, Treanor, John, additional, Diazgranados, Carlos A, additional, and Savarino, Stephen, additional

Published
2021
Full Text
View/download PDF

46. LONG-TERM EFFICACY OF DUPILUMAB IN ORAL CORTICOSTEROID-DEPENDENT PATIENTS WITH ASTHMA: LIBERTY ASTHMA TRAVERSE

Author

Sher, Lawrence, primary, Wechsler, Michael, additional, Rabe, Klaus, additional, maspero, jorge, additional, Daizadeh, Nadia, additional, Mao, Xuezhou, additional, Ortiz, Benjamin, additional, Mannent, Leda, additional, Laws, Elizabeth, additional, Ruddy, Marcella, additional, Pandit-Abid, Namrata, additional, Lederer, David, additional, and Hardin, Megan, additional

Published
2021
Full Text
View/download PDF

48. Dupilumab sustains long-term OCS reduction in OCS-dependent asthma patients

Author

Sher, Lawrence, primary, Wechsler, Michael E., additional, Rabe, Klaus F., additional, Maspero, Jorge F., additional, Daizadeh, Nadia, additional, Mao, Xuezhou, additional, Ortiz, Benjamin, additional, Mannent, Leda P., additional, Laws, Elizabeth, additional, Ruddy, Marcella, additional, Pandit-Abid, Nami, additional, Lederer, David J., additional, and Hardin, Megan, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results